Evidence map›Paper›PMID 37887184›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Naturally Derived Malabaricone B as a Promising Bactericidal Candidate Targeting Multidrug-Resistant

Neethu Sivadas, Grace Kaul, Abdul Akhir, Manjulika Shukla, Murugan Govindakurup Govind, Mathew Dan, Kokkuvayil Vasu Radhakrishnan, Sidharth Chopra

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Polyphenolic compounds inFrontiers in pharmacology · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Neethu SivadasChemical Sciences and Technology Division, CSIR-National Institute for Interdisciplinary Science and Technology, Thiruvananthapuram 695019, India.
Grace KaulAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.ORCID 0000-0002-2820-9573
Abdul AkhirDivision of Microbiology, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow 226031, India.ORCID 0000-0002-7892-4997
Manjulika ShuklaDivision of Microbiology, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow 226031, India.ORCID 0000-0002-9137-5259
Murugan Govindakurup GovindDepartment of Plant Genetics Resource, Jawaharlal Nehru Tropical Botanic Garden and Research Institute, Palode, Thiruvananthapuram 695562, India.ORCID 0000-0002-9244-2919
Mathew DanDepartment of Plant Genetics Resource, Jawaharlal Nehru Tropical Botanic Garden and Research Institute, Palode, Thiruvananthapuram 695562, India.
Kokkuvayil Vasu RadhakrishnanChemical Sciences and Technology Division, CSIR-National Institute for Interdisciplinary Science and Technology, Thiruvananthapuram 695019, India.
Sidharth ChopraAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.ORCID 0000-0001-8823-6074
Central Drug Research Institute · INJawaharlal Nehru Tropical Botanic Garden and Research Institute · INNational Institute for Interdisciplinary Science and Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of multidrug-resistant (MDR) superbugs underlines the urgent need for innovative treatment options to tackle resistant bacterial infections. The clinical efficacy of natural products directed our efforts towards developing new antibacterial leads from naturally abundant known chemical structures. The present study aimed to explore an unusual class of phenylacylphenols (malabaricones) from

Indexed as

malabariconeBmultidrug resistancenatural productsphenylacylphenolsS. aureussynergy

Identifiers

PMID37887184
PMCPMC10604362
OpenAlexW4387060597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.